Institut Bergonié   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Bordeaux France (1923)

Organization Overview

First Clinical Trial
1993
NCT00379041
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

EORTC - Institut Bergonie, Bordeaux, FR | Fondation Bergonié | Institut Bergonié | Institut Bergonié BORDEAUX | Institut Bergonie Cancer Center